BEGIN:VCALENDAR
VERSION:2.0
PRODID:talks.ox.ac.uk
BEGIN:VEVENT
SUMMARY:How do you get from an idea to a marketed drug?  Part 2:Drug Disco
 very – Where to start\, which data do I need\, what is a validated targe
 t? - Dr Steve Rees\, Vice President Discovery Biology (Astra Zeneca)
DTSTART;VALUE=DATE-TIME:20211027T110000
DTEND;VALUE=DATE-TIME:20211027T120000
UID:https://new.talks.ox.ac.uk/talks/id/d9aa8b86-236e-4cf6-86ee-0053fd2fbb
 6b/
DESCRIPTION:The TRO invites you to a weekly series of webinars to explore 
 the key steps in the discovery and development of new medicines\, helping 
 you to transform great ideas into successful innovations. You will be guid
 ed by successful scientists\, entrepreneurs and experts through the key st
 eps to successfully develop a new therapeutics idea into innovations that 
 can change clinical practices and improve patient lives. \nIn this webinar
  series\, we will explore the pre-clinical drug discovery process and iden
 tify where the value is in your project\, what are the handover points fro
 m discovery to development\, how to build a market and commercial strategy
  for your new drug candidate\, how and when to engage with pharma\, and ho
 w to develop a robust intellectual property and investment strategy.\nThe 
 series will commence on 20th October 2021.\n\nSERIES OF EVENTS:\n\nWeek 1 
 (Oct 20th): Introduction session - How do you get from an idea to a market
 ed drug?\nWeek 2 (Oct 27th): Drug Discovery – Where to start\, which dat
 a do I need\, what is a validated target?\nWeek 3 (Nov 3rd ): Drug develop
 ment\nWeek 4 (Nov 10th): Engaging with pharma\nWeek 5 (Nov 17th): Commerci
 alisation strategies: what’s the business case?\nWeek 6 (Nov 24th): Inve
 stment opportunities: who funds what?\nSpeakers:\nDr Steve Rees\, Vice Pre
 sident Discovery Biology (Astra Zeneca)
LOCATION:Venue to be announced
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/d9aa8b86-236e-4cf6-86ee-0053fd2fbb
 6b/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:How do you get from an idea to a marketed drug?  Part 2:D
 rug Discovery – Where to start\, which data do I need\, what is a valida
 ted target? - Dr Steve Rees\, Vice President Discovery Biology (Astra Zene
 ca)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
END:VCALENDAR